Navigation Links
Genta Receives NASDAQ Non-Compliance Notice
Date:12/24/2007

BERKELEY HEIGHTS, N.J., Dec. 24 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA) announced today that the Company has been notified by the Listing Qualifications Staff of The NASDAQ Stock Market that it no longer complies with NASDAQ Marketplace Rule 4450(a)(5), which requires a minimum closing bid price of $1.00 per share. In accordance with Marketplace Rule 4450(e)(2), the Company has until June 16, 2008 to regain compliance, which requires a closing bid price of the Company's common stock at or above $1.00 per share for a minimum of 10 consecutive business days. In the event the Company does not regain compliance within this period, the Company may appeal a delisting determination by the Staff to the NASDAQ Listing Qualifications Panel, and the Company's securities would remain listed pending the Panel's decision.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its DNA/RNA Medicines program. Genta is currently recruiting patients to the AGENDA Trial, a global Phase 3 trial of Genasense in patients with advanced melanoma. The leading drug in Genta's Small Molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer-related hypercalcemia that is resistant to hydration. The Company has developed G4544, an oral formulation of the active ingredient in Ganite, that has recently entered clinical
'/>"/>

SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Genta Announces Presentation of New Clinical and Preclinical Data on Genasense(R) at AACR-NCI-EORTC Targets Conference
2. Syngenta Licenses Chromatin Gene Stacking Technology
3. Genta Completes Appeal of FDA Decision for Genasense(R) in CLL
4. Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market
5. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
6. Genta Incorporated to Present at Lazard Capital Markets 4th Annual Healthcare Conference
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
9. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
10. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
11. IsoTis Receives FDA Clearance for Accell Family of Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Edison Investment Research, ... the initiation of full coverage of BioAlliance ... and marketing products for orphan oncology and ... (Logo: http://photos.prnewswire.com/prnh/20130417/608168) Edison has today ... merits of BioAlliance Pharma, focusing in particular ...
(Date:6/18/2013)... DALLAS , June 18, 2013 ... Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) ... analyzes and studies the Major Market Drivers, Restraints, and Opportunities ... , Asia-Pacific and Rest of ... Data Tables 22 Figures ...
(Date:6/18/2013)... -- Techne Corporation (NASDAQ: TECH ) (Techne) ... 100% ownership of Bionostics Holdings Limited and its ... global leader in the development, manufacture and distribution ... of in vitro diagnostic (IVD) devices ... and blood gas testing.  Biosnostics has strategic supply ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/5g3rx5/dna_sequencing ) has announced the addition of ... Markets and Companies " to their offering. ... This report briefly reviews basics of human ... their applications. Current large and small sequencers ...
Breaking Biology Technology:Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3Techne Corporation Announces Acquisition Agreement 2Techne Corporation Announces Acquisition Agreement 3Techne Corporation Announces Acquisition Agreement 4Techne Corporation Announces Acquisition Agreement 5DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2
... Tests Improve Cancer Identification, Help Physicians Develop More Specific ... ... March 3 The Center for Molecular,Medicine (CMM) today announced an ... physicians personalize cancer,treatment., The AviaraDx tests can provide physicians greater ...
... - Trent 1000 engines have been selected, - New environmental partnership ... ... burn, SOUTH NORWALK, Conn., March 3 ... has selected,Rolls-Royce Trent 1000 engines to power its Boeing 787-9 fleet of ...
... ROBODOC, a Curexo,Technology Company, and IBM announced ... Cross licensing agreement. The terms of the agreement ... to its current surgical robotics patents, this agreement,gives ... IBM,S Global Portfolio,and particularly, IBM,s surgical robotics patents., ...
Cached Biology Technology:Center for Molecular Medicine Partners with AviaraDx to Offer New Cancer Tests to Aid Physicians in Personalizing Treatment 2Center for Molecular Medicine Partners with AviaraDx to Offer New Cancer Tests to Aid Physicians in Personalizing Treatment 3Virgin Atlantic Selects Rolls-Royce Engines to Power Its 787 Fleet in a Deal Worth $2.6BN 2Virgin Atlantic Selects Rolls-Royce Engines to Power Its 787 Fleet in a Deal Worth $2.6BN 3Virgin Atlantic Selects Rolls-Royce Engines to Power Its 787 Fleet in a Deal Worth $2.6BN 4ROBODOC(R) Announces Patent Cross Licensing Agreement With IBM 2
(Date:6/18/2013)... June 18, 2013 The herbal extract of a ... found to increase the lifespan of fruit fly populations ... Irvine researchers. , But it,s how Rhodiola ... this that grabbed the attention of study leaders Mahtab ... works in a manner completely unrelated to dietary ...
(Date:6/18/2013)... of internationally recognized feline experts including veterinarians and feline ... of Lincoln, U.K. and Dr Ilona Rodan, Director of ... International Society of Feline Medicine (ISFM) and the American ... veterinarians, owners and those working with cats on how ... The new guidelines appear in the Journal of ...
(Date:6/17/2013)... with central nervous system infections may well be suffering ... to a study to be published in mBio ... for Microbiology. Researchers have detected the virus in spinal ... nervous system infections of unknown cause, and in an ... and poultry, suggesting animals may serve as reservoirs for ...
Breaking Biology News(10 mins):Herbal extract boosts fruit fly lifespan by nearly 25 percent, UCI study finds 2Feline behavior experts release guidelines to improve the welfare of cats 2New virus discovered in patients with central nervous system infections 2New virus discovered in patients with central nervous system infections 3
... is available in French . Researchers ... Council of Canada, the University of Toronto and the ... a highly unique spring located on Axel Heiberg Island ... microbiologist explains that the Lost Hammer spring supports microbial ...
... new therapy mounts a double-barreled attack on leukemia, targeting not ... those cells live and grow, University of Florida researchers report. ... cutting off its source of food and other resources, the ... vessels that supply them with oxygen and nutrients. Use ...
... of a brown algal genome, an international research team ... of two key prerequisites for higher life on Earth ... magazine Nature reported in its latest issue, ... project, successfully decoded all hereditary information commonly known ...
Cached Biology News:Could life survive on Mars? Yes, expert says 2UF oncologists fight leukemia with two-pronged therapy, clinical trials planned 2UF oncologists fight leukemia with two-pronged therapy, clinical trials planned 3How did higher life evolve? 2How did higher life evolve? 3
... TempliPhi 100 Amplification Kit, 100 reactions. ... sequencing in 4-6 h.Generate microgram quantities ... of starting material.Use amplified DNA directly ... from bacterial or M13 liquid cultures, ...
... Amplification Kit, 500 reactions. Prepare circular ... 4-6 h.Generate microgram quantities of template ... material.Use amplified DNA directly for cycle ... or M13 liquid cultures, colonies, plaques, ...
Attachments: Clip bar for tubes 10 to 19 mm in diameter Overall Dimension Height IC: 6 (15.2) Overall Dimension Length IC: 18.5 (46.9) Overall Dimension Width IC: 4 (10.2)...
Mixing speed from 750-3200RPM, small vortexing orbit of1.0mm...
Biology Products: